Bisacodyl Tablet, Delayed Release
FDA Label NDC 71335-2010

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Bisacodyl (NDC 71335-2010). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

How Supplied

NDC: 71335-2010-0: 25 Tablets in a BOTTLE

NDC: 71335-2010-1: 30 Tablets in a BOTTLE

NDC: 71335-2010-2: 2 Tablets in a BOTTLE

NDC: 71335-2010-3: 3 Tablets in a BOTTLE

NDC: 71335-2010-4: 4 Tablets in a BOTTLE

NDC: 71335-2010-5: 10 Tablets in a BOTTLE

NDC: 71335-2010-6: 90 Tablets in a BOTTLE

NDC: 71335-2010-7: 8 Tablets in a BOTTLE

NDC: 71335-2010-8: 100 Tablets in a BOTTLE

NDC: 71335-2010-9: 20 Tablets in a BOTTLE

Package Label.Principal Display Panel

Bisacodyl 5mg Tablet

Label (Lbl713352010)

Label (Lbl713352010)

* Please review the disclaimer below.